P63 and CK5 expressions are maintained in infiltrating invasive cancer cells whereas Her2/neu expression is reduced in invasive and basally located cancer cells (Fig. 1, arrows in Her2 staining in Days 47 and 53 lesions). Here, KRT5 is linked to cancer.